HYPER IGM IMMUNODEFICIENCY - A PRIMARY DYSFUNCTION OF LYMPHOCYTE-B ISOTYPE SWITCHING

被引:76
作者
LEVITT, D
HABER, P
RICH, K
COOPER, MD
机构
[1] UNIV CHICAGO,DEPT PEDIAT,CHICAGO,IL 60649
[2] UNIV CHICAGO,CHICAGO RES INST,LA RABIDA UNIV,CHICAGO,IL 60649
[3] UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35294
[4] UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294
[5] UNIV ALABAMA,CTR COMPREHENS CANC,BIRMINGHAM,AL 35294
[6] CHILDRENS MEM HOSP,DEPT PEDIAT,CHICAGO,IL 60611
[7] NW MED CTR,CHICAGO,IL 60611
关键词
D O I
10.1172/JCI111124
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:1650 / 1657
页数:8
相关论文
共 51 条
[41]   ISOTYPE-SPECIFIC T-CELL REGULATION OF IMMUNOGLOBULIN EXPRESSION [J].
ROSENBERG, YJ .
IMMUNOLOGICAL REVIEWS, 1982, 67 :33-58
[42]   SUPPRESSOR CELL ACTIVITY AFTER CONCANAVALIN A TREATMENT OF LYMPHOCYTES FROM NORMAL DONORS [J].
SHOU, L ;
SCHWARTZ, SA ;
GOOD, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (05) :1100-1110
[43]   ROLE OF HELPER, SUPPRESSOR AND B-CELL DEFECTS IN PATHOGENESIS OF HYPO-GAMMAGLOBULINEMIAS [J].
SIEGAL, FP ;
SIEGAL, M ;
GOOD, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (04) :172-178
[44]   SUPPRESSION OF B-CELL DIFFERENTIATION BY LEUKOCYTES FROM HYPOGAMMAGLOBULINEMIC PATIENTS [J].
SIEGAL, FP ;
SIEGAL, M ;
GOOD, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (01) :109-122
[45]   EVIDENCE THAT POKEWEED-MITOGEN-REACTIVE B-CELLS ARE PRE-COMMITTED INVIVO TO THE HIGH-RATE SECRETION OF A SINGLE IMMUNOGLOBULIN ISOTYPE INVITRO [J].
STEVENS, RH ;
MACY, E ;
THIELE, CJ .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1981, 14 (05) :449-457
[46]   DIVERSITY OF IMMUNOGLOBULIN EXPRESSION IN LEUKEMIC-CELLS RESEMBLING LYMPHOCYTE-B PRECURSORS [J].
VOGLER, LB ;
PREUDHOMME, JL ;
SELIGMANN, M ;
GATHINGS, WE ;
CRIST, WM ;
COOPER, MD ;
BOLLUM, FJ .
NATURE, 1981, 290 (5804) :339-341
[47]  
Waldmann T A, 1976, Trans Assoc Am Physicians, V89, P215
[48]   POLYCLONAL B-CELL ACTIVATORS IN THE STUDY OF THE REGULATION OF IMMUNOGLOBULIN-SYNTHESIS IN THE HUMAN SYSTEM [J].
WALDMANN, TA ;
BRODER, S .
ADVANCES IN IMMUNOLOGY, 1982, 32 :1-63
[49]  
WALDMANN TA, 1974, LANCET, V2, P609
[50]  
WATANABE T, 1978, J IMMUNOL, V121, P2113